Nose and Paranasal Sinuses Clinical Trials

• Normal Paranasal Sinuses Microflora Study
  ClinicalTrials.gov Identifier: NCT00426569 - Recruiting
  Paranasal Sinuses; Flora
  
• Near Infrared Transillumination of the Paranasal Sinuses
  ClinicalTrials.gov Identifier: NCT00543998 - Enrolling by invitation
  Sinusitis
  
• Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)
  ClinicalTrials.gov Identifier: NCT00231062 - Completed
  Chronic Sinusitis
  
• Fluorouracil, Hydroxyurea, Cetuximab and Twice-Daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00462735 - Recruiting
  Head and Neck Cancer; Cancer of the Pharynx; Cancer of the Larynx; Nose Neoplasms; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
  
• Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer
  ClinicalTrials.gov Identifier: NCT00347256 - Not yet recruiting
  Paranasal Sinus Neoplasms
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005814 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
  Nose Cancer; Oral Cancer
  
• Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00084435 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095628 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004865 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00003200 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003582 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer; Quality of Life
  
• Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022217 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Modern Ultrasound Techniques in the Evaluation of Cerebral Venous Sinuses in Neonates
  ClinicalTrials.gov Identifier: NCT00555932 - Recruiting
  Intracranial Thrombosis
  
• Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003576 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer
  
• Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00089297 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003777 - Active, not recruiting
  Oral Cancer; Throat Cancer; Nose Cancer
  
• Docetaxel Based Chemotherapy Plus Or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
  ClinicalTrials.gov Identifier: NCT00117572 - Recruiting
  Cancer of the Pharynx; Cancer of the Larynx; Cancer of the Nasal Cavity; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
  
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003592 - Active, not recruiting
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Cleaning of the Nose After Sinus Surgery: Necessary or Only Bothersome?
  ClinicalTrials.gov Identifier: NCT00184392 - Active, not recruiting
  Acute Recurrent Rhinosinusitis
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer
  ClinicalTrials.gov Identifier: NCT00007982 - Recruiting
  adult brain tumor; paranasal sinus and nasal cavity cancer; primary central nervous system lymphoma
  
• Mastoid Bone Autograft for Dorsal Nasal Augmentation
  ClinicalTrials.gov Identifier: NCT00545428 - Recruiting
  Nose Deformities, Acquired
  
• Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095641 - Not yet recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
  ClinicalTrials.gov Identifier: NCT00195611 - Active, not recruiting
  Otitis Media; Otitis Media With Effusion; Pneumococcal Infections
  
• Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00083057 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...
  
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002659 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003257 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003856 - Active, not recruiting
  recurrent squamous cell carcinoma of the oropharynx; recurrent squamous cell carcinoma of the hypopharynx; recurrent salivary gland cancer; ...
  
• ZD1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00015964 - Completed
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00004226 - Active, not recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the hypopharynx; ...
  
• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006248 - Completed
  Nose Cancers; Oral Cancer; Throat Cancer
  
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002506 - Active, not recruiting
  recurrent non-small cell lung cancer; recurrent cervical cancer; recurrent squamous cell carcinoma of the lip and oral cavity; ...
  
• BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00057850 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
  ClinicalTrials.gov Identifier: NCT00052429 - Active, not recruiting
  stage II lymphoepithelioma of the nasopharynx; stage II squamous cell carcinoma of the nasopharynx; stage III lymphoepithelioma of the nasopharynx; ...
  
• Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002922 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses
  ClinicalTrials.gov Identifier: NCT00249210 - Completed
  Maxillary Sinusitis; Sinusitis
  
• Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003443 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003908 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; metastatic squamous neck cancer with occult primary squamous cell carcinoma; ...
  
• Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003850 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; metastatic squamous neck cancer with occult primary squamous cell carcinoma; ...
  
• Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00017511 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Nasopharyngeal Cancer; ...
  
• Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005087 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Oropharyngeal Cancer; ...
  
• Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
  ClinicalTrials.gov Identifier: NCT00074594 - Completed
  Nasopharyngeal Cancer; Epstein-Barr Virus Infections
  
• Lapatinib in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00114283 - Suspended
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...